nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—clitoris—ovarian cancer	0.124	0.334	CbGeAlD
Pentoxifylline—NT5E—myometrium—ovarian cancer	0.0121	0.0326	CbGeAlD
Pentoxifylline—NT5E—embryo—ovarian cancer	0.0116	0.0313	CbGeAlD
Pentoxifylline—NT5E—epithelium—ovarian cancer	0.00949	0.0256	CbGeAlD
Pentoxifylline—NT5E—uterine cervix—ovarian cancer	0.00941	0.0253	CbGeAlD
Pentoxifylline—NT5E—decidua—ovarian cancer	0.00896	0.0242	CbGeAlD
Pentoxifylline—NT5E—endometrium—ovarian cancer	0.00851	0.0229	CbGeAlD
Pentoxifylline—Caffeine—PIK3CD—ovarian cancer	0.00821	0.315	CrCbGaD
Pentoxifylline—Caffeine—PIK3CB—ovarian cancer	0.00821	0.315	CrCbGaD
Pentoxifylline—NT5E—gonad—ovarian cancer	0.00789	0.0213	CbGeAlD
Pentoxifylline—NT5E—uterus—ovarian cancer	0.00784	0.0211	CbGeAlD
Pentoxifylline—ADORA2B—decidua—ovarian cancer	0.00768	0.0207	CbGeAlD
Pentoxifylline—NT5E—female reproductive system—ovarian cancer	0.00705	0.019	CbGeAlD
Pentoxifylline—PDE4A—decidua—ovarian cancer	0.00684	0.0184	CbGeAlD
Pentoxifylline—NT5E—bone marrow—ovarian cancer	0.00665	0.0179	CbGeAlD
Pentoxifylline—NT5E—female gonad—ovarian cancer	0.00641	0.0173	CbGeAlD
Pentoxifylline—NT5E—vagina—ovarian cancer	0.00637	0.0172	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—ovarian cancer	0.00635	0.243	CrCbGaD
Pentoxifylline—PDE5A—epithelium—ovarian cancer	0.00616	0.0166	CbGeAlD
Pentoxifylline—PDE5A—uterine cervix—ovarian cancer	0.00611	0.0164	CbGeAlD
Pentoxifylline—NT5E—testis—ovarian cancer	0.00569	0.0153	CbGeAlD
Pentoxifylline—ADORA2A—gonad—ovarian cancer	0.00562	0.0152	CbGeAlD
Pentoxifylline—ADORA2B—vagina—ovarian cancer	0.00546	0.0147	CbGeAlD
Pentoxifylline—PDE5A—gonad—ovarian cancer	0.00512	0.0138	CbGeAlD
Pentoxifylline—ADORA2A—female reproductive system—ovarian cancer	0.00502	0.0135	CbGeAlD
Pentoxifylline—PDE4A—female gonad—ovarian cancer	0.0049	0.0132	CbGeAlD
Pentoxifylline—ADORA2B—testis—ovarian cancer	0.00487	0.0131	CbGeAlD
Pentoxifylline—PDE5A—female reproductive system—ovarian cancer	0.00457	0.0123	CbGeAlD
Pentoxifylline—PDE4A—testis—ovarian cancer	0.00434	0.0117	CbGeAlD
Pentoxifylline—ADORA1—female reproductive system—ovarian cancer	0.00434	0.0117	CbGeAlD
Pentoxifylline—PDE4B—uterine cervix—ovarian cancer	0.00428	0.0115	CbGeAlD
Pentoxifylline—PDE5A—female gonad—ovarian cancer	0.00416	0.0112	CbGeAlD
Pentoxifylline—PDE5A—vagina—ovarian cancer	0.00414	0.0111	CbGeAlD
Pentoxifylline—NT5E—lymph node—ovarian cancer	0.00412	0.0111	CbGeAlD
Pentoxifylline—PDE4B—decidua—ovarian cancer	0.00408	0.011	CbGeAlD
Pentoxifylline—ADORA2A—testis—ovarian cancer	0.00405	0.0109	CbGeAlD
Pentoxifylline—ADORA1—vagina—ovarian cancer	0.00392	0.0106	CbGeAlD
Pentoxifylline—PDE4B—endometrium—ovarian cancer	0.00387	0.0104	CbGeAlD
Pentoxifylline—PDE5A—testis—ovarian cancer	0.00369	0.00995	CbGeAlD
Pentoxifylline—PDE4B—gonad—ovarian cancer	0.00359	0.00968	CbGeAlD
Pentoxifylline—ADORA1—testis—ovarian cancer	0.0035	0.00943	CbGeAlD
Pentoxifylline—PDE4B—female reproductive system—ovarian cancer	0.00321	0.00864	CbGeAlD
Pentoxifylline—PDE4A—lymph node—ovarian cancer	0.00315	0.00848	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—ovarian cancer	0.00303	0.00816	CbGeAlD
Pentoxifylline—PDE4B—female gonad—ovarian cancer	0.00292	0.00786	CbGeAlD
Pentoxifylline—PDE4B—vagina—ovarian cancer	0.0029	0.00782	CbGeAlD
Pentoxifylline—PDE5A—lymph node—ovarian cancer	0.00268	0.00721	CbGeAlD
Pentoxifylline—PDE4B—testis—ovarian cancer	0.00259	0.00697	CbGeAlD
Pentoxifylline—Caffeine—CYP1B1—ovarian cancer	0.00258	0.099	CrCbGaD
Pentoxifylline—ADORA1—lymph node—ovarian cancer	0.00254	0.00683	CbGeAlD
Pentoxifylline—PDE4B—lymph node—ovarian cancer	0.00188	0.00506	CbGeAlD
Pentoxifylline—Rash—Topotecan—ovarian cancer	0.000776	0.00159	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vinorelbine—ovarian cancer	0.000776	0.00159	CcSEcCtD
Pentoxifylline—Dermatitis—Topotecan—ovarian cancer	0.000775	0.00158	CcSEcCtD
Pentoxifylline—Headache—Topotecan—ovarian cancer	0.000771	0.00158	CcSEcCtD
Pentoxifylline—Palpitations—Paclitaxel—ovarian cancer	0.000767	0.00157	CcSEcCtD
Pentoxifylline—Vomiting—Melphalan—ovarian cancer	0.000766	0.00157	CcSEcCtD
Pentoxifylline—Immune system disorder—Docetaxel—ovarian cancer	0.000763	0.00156	CcSEcCtD
Pentoxifylline—Rash—Melphalan—ovarian cancer	0.00076	0.00155	CcSEcCtD
Pentoxifylline—Dermatitis—Melphalan—ovarian cancer	0.000759	0.00155	CcSEcCtD
Pentoxifylline—Asthenia—Vinorelbine—ovarian cancer	0.000755	0.00154	CcSEcCtD
Pentoxifylline—Arrhythmia—Docetaxel—ovarian cancer	0.000755	0.00154	CcSEcCtD
Pentoxifylline—Convulsion—Paclitaxel—ovarian cancer	0.000752	0.00154	CcSEcCtD
Pentoxifylline—Hypertension—Paclitaxel—ovarian cancer	0.000749	0.00153	CcSEcCtD
Pentoxifylline—Pruritus—Vinorelbine—ovarian cancer	0.000745	0.00152	CcSEcCtD
Pentoxifylline—Caffeine—ABCB1—ovarian cancer	0.000741	0.0284	CrCbGaD
Pentoxifylline—Chest pain—Paclitaxel—ovarian cancer	0.000739	0.00151	CcSEcCtD
Pentoxifylline—Myalgia—Paclitaxel—ovarian cancer	0.000739	0.00151	CcSEcCtD
Pentoxifylline—Anxiety—Paclitaxel—ovarian cancer	0.000736	0.0015	CcSEcCtD
Pentoxifylline—Erythema—Docetaxel—ovarian cancer	0.000735	0.0015	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000734	0.0015	CcSEcCtD
Pentoxifylline—Nausea—Topotecan—ovarian cancer	0.000731	0.00149	CcSEcCtD
Pentoxifylline—Discomfort—Paclitaxel—ovarian cancer	0.00073	0.00149	CcSEcCtD
Pentoxifylline—Dry mouth—Paclitaxel—ovarian cancer	0.000722	0.00148	CcSEcCtD
Pentoxifylline—Diarrhoea—Vinorelbine—ovarian cancer	0.00072	0.00147	CcSEcCtD
Pentoxifylline—Dysgeusia—Docetaxel—ovarian cancer	0.00072	0.00147	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—ovarian cancer	0.000717	0.00147	CcSEcCtD
Pentoxifylline—Nausea—Melphalan—ovarian cancer	0.000716	0.00146	CcSEcCtD
Pentoxifylline—Confusional state—Paclitaxel—ovarian cancer	0.000714	0.00146	CcSEcCtD
Pentoxifylline—Back pain—Docetaxel—ovarian cancer	0.000711	0.00145	CcSEcCtD
Pentoxifylline—Oedema—Paclitaxel—ovarian cancer	0.000708	0.00145	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000708	0.00145	CcSEcCtD
Pentoxifylline—Muscle spasms—Docetaxel—ovarian cancer	0.000707	0.00145	CcSEcCtD
Pentoxifylline—Infection—Paclitaxel—ovarian cancer	0.000704	0.00144	CcSEcCtD
Pentoxifylline—Shock—Paclitaxel—ovarian cancer	0.000697	0.00142	CcSEcCtD
Pentoxifylline—Dizziness—Vinorelbine—ovarian cancer	0.000696	0.00142	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—ovarian cancer	0.000694	0.00142	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000693	0.00142	CcSEcCtD
Pentoxifylline—Tachycardia—Paclitaxel—ovarian cancer	0.000691	0.00141	CcSEcCtD
Pentoxifylline—Skin disorder—Paclitaxel—ovarian cancer	0.000688	0.00141	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000685	0.0014	CcSEcCtD
Pentoxifylline—Anaemia—Docetaxel—ovarian cancer	0.00068	0.00139	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—ovarian cancer	0.000676	0.00138	CcSEcCtD
Pentoxifylline—Anorexia—Paclitaxel—ovarian cancer	0.000675	0.00138	CcSEcCtD
Pentoxifylline—Vomiting—Vinorelbine—ovarian cancer	0.000669	0.00137	CcSEcCtD
Pentoxifylline—Rash—Vinorelbine—ovarian cancer	0.000664	0.00136	CcSEcCtD
Pentoxifylline—Dermatitis—Vinorelbine—ovarian cancer	0.000663	0.00136	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—ovarian cancer	0.000663	0.00136	CcSEcCtD
Pentoxifylline—Hypotension—Paclitaxel—ovarian cancer	0.000662	0.00135	CcSEcCtD
Pentoxifylline—Headache—Vinorelbine—ovarian cancer	0.00066	0.00135	CcSEcCtD
Pentoxifylline—Leukopenia—Docetaxel—ovarian cancer	0.000658	0.00135	CcSEcCtD
Pentoxifylline—Palpitations—Docetaxel—ovarian cancer	0.00065	0.00133	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000645	0.00132	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—ovarian cancer	0.000642	0.00131	CcSEcCtD
Pentoxifylline—Insomnia—Paclitaxel—ovarian cancer	0.000641	0.00131	CcSEcCtD
Pentoxifylline—Convulsion—Docetaxel—ovarian cancer	0.000637	0.0013	CcSEcCtD
Pentoxifylline—Hypertension—Docetaxel—ovarian cancer	0.000635	0.0013	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—ovarian cancer	0.000635	0.0013	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—ovarian cancer	0.000635	0.0013	CcSEcCtD
Pentoxifylline—Infestation—Epirubicin—ovarian cancer	0.000635	0.0013	CcSEcCtD
Pentoxifylline—Dyspnoea—Paclitaxel—ovarian cancer	0.000631	0.00129	CcSEcCtD
Pentoxifylline—Somnolence—Paclitaxel—ovarian cancer	0.00063	0.00129	CcSEcCtD
Pentoxifylline—Myalgia—Docetaxel—ovarian cancer	0.000626	0.00128	CcSEcCtD
Pentoxifylline—Chest pain—Docetaxel—ovarian cancer	0.000626	0.00128	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—ovarian cancer	0.000626	0.00128	CcSEcCtD
Pentoxifylline—Nausea—Vinorelbine—ovarian cancer	0.000625	0.00128	CcSEcCtD
Pentoxifylline—Dyspepsia—Paclitaxel—ovarian cancer	0.000623	0.00127	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000622	0.00127	CcSEcCtD
Pentoxifylline—Jaundice—Epirubicin—ovarian cancer	0.000619	0.00126	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—ovarian cancer	0.000617	0.00126	CcSEcCtD
Pentoxifylline—Decreased appetite—Paclitaxel—ovarian cancer	0.000616	0.00126	CcSEcCtD
Pentoxifylline—Dry mouth—Docetaxel—ovarian cancer	0.000612	0.00125	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—ovarian cancer	0.000609	0.00124	CcSEcCtD
Pentoxifylline—Constipation—Paclitaxel—ovarian cancer	0.000606	0.00124	CcSEcCtD
Pentoxifylline—Confusional state—Docetaxel—ovarian cancer	0.000605	0.00124	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—ovarian cancer	0.0006	0.00123	CcSEcCtD
Pentoxifylline—Oedema—Docetaxel—ovarian cancer	0.0006	0.00123	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Docetaxel—ovarian cancer	0.0006	0.00123	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—ovarian cancer	0.000599	0.00122	CcSEcCtD
Pentoxifylline—Infection—Docetaxel—ovarian cancer	0.000596	0.00122	CcSEcCtD
Pentoxifylline—Shock—Docetaxel—ovarian cancer	0.000591	0.00121	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Docetaxel—ovarian cancer	0.000588	0.0012	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—ovarian cancer	0.000587	0.0012	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—ovarian cancer	0.000587	0.0012	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—ovarian cancer	0.000587	0.0012	CcSEcCtD
Pentoxifylline—Tachycardia—Docetaxel—ovarian cancer	0.000586	0.0012	CcSEcCtD
Pentoxifylline—Feeling abnormal—Paclitaxel—ovarian cancer	0.000584	0.00119	CcSEcCtD
Pentoxifylline—Skin disorder—Docetaxel—ovarian cancer	0.000583	0.00119	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000579	0.00118	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—ovarian cancer	0.000573	0.00117	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—ovarian cancer	0.000573	0.00117	CcSEcCtD
Pentoxifylline—Anorexia—Docetaxel—ovarian cancer	0.000572	0.00117	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—ovarian cancer	0.000571	0.00117	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—ovarian cancer	0.00057	0.00116	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—ovarian cancer	0.00057	0.00116	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—ovarian cancer	0.000563	0.00115	CcSEcCtD
Pentoxifylline—Urticaria—Paclitaxel—ovarian cancer	0.000563	0.00115	CcSEcCtD
Pentoxifylline—Hypotension—Docetaxel—ovarian cancer	0.000561	0.00115	CcSEcCtD
Pentoxifylline—Abdominal pain—Paclitaxel—ovarian cancer	0.00056	0.00114	CcSEcCtD
Pentoxifylline—Body temperature increased—Paclitaxel—ovarian cancer	0.00056	0.00114	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000556	0.00114	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—ovarian cancer	0.000554	0.00113	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000547	0.00112	CcSEcCtD
Pentoxifylline—Insomnia—Docetaxel—ovarian cancer	0.000543	0.00111	CcSEcCtD
Pentoxifylline—Dyspnoea—Docetaxel—ovarian cancer	0.000535	0.00109	CcSEcCtD
Pentoxifylline—Somnolence—Docetaxel—ovarian cancer	0.000534	0.00109	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—ovarian cancer	0.00053	0.00108	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—ovarian cancer	0.000529	0.00108	CcSEcCtD
Pentoxifylline—Dyspepsia—Docetaxel—ovarian cancer	0.000528	0.00108	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—ovarian cancer	0.000527	0.00108	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—ovarian cancer	0.000527	0.00108	CcSEcCtD
Pentoxifylline—Decreased appetite—Docetaxel—ovarian cancer	0.000522	0.00107	CcSEcCtD
Pentoxifylline—Hypersensitivity—Paclitaxel—ovarian cancer	0.000522	0.00107	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—ovarian cancer	0.000515	0.00105	CcSEcCtD
Pentoxifylline—Constipation—Docetaxel—ovarian cancer	0.000513	0.00105	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—ovarian cancer	0.000509	0.00104	CcSEcCtD
Pentoxifylline—Asthenia—Paclitaxel—ovarian cancer	0.000508	0.00104	CcSEcCtD
Pentoxifylline—Pruritus—Paclitaxel—ovarian cancer	0.000501	0.00102	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—ovarian cancer	0.000496	0.00101	CcSEcCtD
Pentoxifylline—Feeling abnormal—Docetaxel—ovarian cancer	0.000495	0.00101	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000491	0.001	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—ovarian cancer	0.000489	0.001	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—ovarian cancer	0.000489	0.000999	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—ovarian cancer	0.000487	0.000995	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—ovarian cancer	0.000486	0.000993	CcSEcCtD
Pentoxifylline—Diarrhoea—Paclitaxel—ovarian cancer	0.000485	0.000991	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—ovarian cancer	0.000482	0.000985	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—ovarian cancer	0.00048	0.000981	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—ovarian cancer	0.000477	0.000975	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—ovarian cancer	0.000476	0.000974	CcSEcCtD
Pentoxifylline—Body temperature increased—Docetaxel—ovarian cancer	0.000475	0.00097	CcSEcCtD
Pentoxifylline—Abdominal pain—Docetaxel—ovarian cancer	0.000475	0.00097	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—ovarian cancer	0.000471	0.000963	CcSEcCtD
Pentoxifylline—Dizziness—Paclitaxel—ovarian cancer	0.000468	0.000957	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—ovarian cancer	0.000468	0.000956	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—ovarian cancer	0.00046	0.000941	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—ovarian cancer	0.000459	0.000938	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—ovarian cancer	0.000459	0.000937	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—ovarian cancer	0.000456	0.000932	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—ovarian cancer	0.000452	0.000925	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—ovarian cancer	0.00045	0.000921	CcSEcCtD
Pentoxifylline—Vomiting—Paclitaxel—ovarian cancer	0.00045	0.00092	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—ovarian cancer	0.000449	0.000919	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—ovarian cancer	0.000447	0.000915	CcSEcCtD
Pentoxifylline—Rash—Paclitaxel—ovarian cancer	0.000447	0.000913	CcSEcCtD
Pentoxifylline—Dermatitis—Paclitaxel—ovarian cancer	0.000446	0.000912	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—ovarian cancer	0.000446	0.000911	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—ovarian cancer	0.000444	0.000908	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—ovarian cancer	0.000444	0.000908	CcSEcCtD
Pentoxifylline—Headache—Paclitaxel—ovarian cancer	0.000444	0.000907	CcSEcCtD
Pentoxifylline—Hypersensitivity—Docetaxel—ovarian cancer	0.000442	0.000904	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—ovarian cancer	0.000441	0.000902	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—ovarian cancer	0.000438	0.000896	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—ovarian cancer	0.000433	0.000884	CcSEcCtD
Pentoxifylline—Asthenia—Docetaxel—ovarian cancer	0.000431	0.00088	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—ovarian cancer	0.00043	0.000879	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—ovarian cancer	0.000428	0.000876	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000426	0.000871	CcSEcCtD
Pentoxifylline—Pruritus—Docetaxel—ovarian cancer	0.000425	0.000868	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—ovarian cancer	0.000424	0.000867	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—ovarian cancer	0.000422	0.000863	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—ovarian cancer	0.000422	0.000863	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—ovarian cancer	0.000422	0.000862	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—ovarian cancer	0.000421	0.00086	CcSEcCtD
Pentoxifylline—Nausea—Paclitaxel—ovarian cancer	0.000421	0.00086	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000419	0.000857	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—ovarian cancer	0.000417	0.000853	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—ovarian cancer	0.000414	0.000846	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—ovarian cancer	0.000413	0.000844	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—ovarian cancer	0.000411	0.00084	CcSEcCtD
Pentoxifylline—Diarrhoea—Docetaxel—ovarian cancer	0.000411	0.00084	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—ovarian cancer	0.000408	0.000835	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—ovarian cancer	0.000406	0.000829	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—ovarian cancer	0.000405	0.000828	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—ovarian cancer	0.000405	0.000828	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—ovarian cancer	0.000402	0.000822	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—ovarian cancer	0.000398	0.000814	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—ovarian cancer	0.000398	0.000813	CcSEcCtD
Pentoxifylline—Dizziness—Docetaxel—ovarian cancer	0.000397	0.000811	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—ovarian cancer	0.000396	0.00081	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—ovarian cancer	0.000396	0.00081	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—ovarian cancer	0.000395	0.000808	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—ovarian cancer	0.000393	0.000804	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—ovarian cancer	0.000391	0.0008	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—ovarian cancer	0.000391	0.000799	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—ovarian cancer	0.000391	0.000799	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—ovarian cancer	0.000389	0.000796	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000388	0.000793	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—ovarian cancer	0.000386	0.000789	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—ovarian cancer	0.000386	0.000789	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—ovarian cancer	0.000382	0.000781	CcSEcCtD
Pentoxifylline—Vomiting—Docetaxel—ovarian cancer	0.000382	0.00078	CcSEcCtD
Pentoxifylline—Rash—Docetaxel—ovarian cancer	0.000378	0.000774	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—ovarian cancer	0.000378	0.000773	CcSEcCtD
Pentoxifylline—Dermatitis—Docetaxel—ovarian cancer	0.000378	0.000773	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—ovarian cancer	0.000378	0.000772	CcSEcCtD
Pentoxifylline—Headache—Docetaxel—ovarian cancer	0.000376	0.000769	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000375	0.000766	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—ovarian cancer	0.000375	0.000766	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—ovarian cancer	0.000372	0.000761	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000369	0.000754	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—ovarian cancer	0.000369	0.000753	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000367	0.00075	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—ovarian cancer	0.000366	0.000749	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—ovarian cancer	0.000366	0.000747	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—ovarian cancer	0.000364	0.000744	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000362	0.00074	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—ovarian cancer	0.000361	0.000738	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—ovarian cancer	0.00036	0.000736	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—ovarian cancer	0.000357	0.00073	CcSEcCtD
Pentoxifylline—Nausea—Docetaxel—ovarian cancer	0.000357	0.000729	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—ovarian cancer	0.000356	0.000729	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—ovarian cancer	0.000352	0.000719	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—ovarian cancer	0.00035	0.000716	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—ovarian cancer	0.000346	0.000708	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000341	0.000698	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—ovarian cancer	0.000339	0.000693	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—ovarian cancer	0.000334	0.000683	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—ovarian cancer	0.000334	0.000682	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—ovarian cancer	0.000333	0.000681	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000331	0.000677	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—ovarian cancer	0.00033	0.000674	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—ovarian cancer	0.000326	0.000666	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—ovarian cancer	0.000322	0.000658	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—ovarian cancer	0.00032	0.000655	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—ovarian cancer	0.00032	0.000654	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—ovarian cancer	0.00032	0.000654	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—ovarian cancer	0.000309	0.000631	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000306	0.000626	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—ovarian cancer	0.000298	0.00061	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—ovarian cancer	0.000298	0.000608	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—ovarian cancer	0.000296	0.000605	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—ovarian cancer	0.000296	0.000605	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—ovarian cancer	0.00029	0.000594	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—ovarian cancer	0.000286	0.000586	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—ovarian cancer	0.000277	0.000566	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—ovarian cancer	0.000276	0.000564	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—ovarian cancer	0.000269	0.000549	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—ovarian cancer	0.000268	0.000547	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—ovarian cancer	0.000265	0.000542	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—ovarian cancer	0.000257	0.000526	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—ovarian cancer	0.000256	0.000524	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—ovarian cancer	0.000255	0.000522	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—ovarian cancer	0.000255	0.000521	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—ovarian cancer	0.000254	0.000518	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—ovarian cancer	0.000248	0.000506	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—ovarian cancer	0.00024	0.000492	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—ovarian cancer	0.000238	0.000487	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—ovarian cancer	0.000236	0.000483	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—ovarian cancer	0.000236	0.000482	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—ovarian cancer	0.000235	0.00048	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—ovarian cancer	0.000223	0.000455	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CB—ovarian cancer	6.51e-05	0.000573	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—ovarian cancer	6.46e-05	0.000569	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TERT—ovarian cancer	6.43e-05	0.000566	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CD—ovarian cancer	6.42e-05	0.000565	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—ovarian cancer	6.33e-05	0.000557	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ESR1—ovarian cancer	6.32e-05	0.000556	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—ovarian cancer	6.25e-05	0.00055	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6ST—ovarian cancer	6.21e-05	0.000547	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—ovarian cancer	6.05e-05	0.000532	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TERT—ovarian cancer	6.02e-05	0.00053	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—ovarian cancer	5.97e-05	0.000526	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—ovarian cancer	5.97e-05	0.000526	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—ovarian cancer	5.97e-05	0.000526	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—ovarian cancer	5.97e-05	0.000526	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TERT—ovarian cancer	5.95e-05	0.000524	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CAV1—ovarian cancer	5.95e-05	0.000524	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PPP2R1A—ovarian cancer	5.86e-05	0.000516	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CD—ovarian cancer	5.83e-05	0.000513	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ESR1—ovarian cancer	5.73e-05	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK3—ovarian cancer	5.72e-05	0.000503	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6ST—ovarian cancer	5.64e-05	0.000497	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	5.6e-05	0.000493	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CAV1—ovarian cancer	5.57e-05	0.000491	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CAV1—ovarian cancer	5.51e-05	0.000485	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK1—ovarian cancer	5.44e-05	0.000479	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—ovarian cancer	5.44e-05	0.000479	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—ovarian cancer	5.42e-05	0.000477	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—ovarian cancer	5.42e-05	0.000477	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—ovarian cancer	5.42e-05	0.000477	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.4e-05	0.000476	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—ovarian cancer	5.39e-05	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—ovarian cancer	5.38e-05	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ESR1—ovarian cancer	5.37e-05	0.000473	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ESR1—ovarian cancer	5.31e-05	0.000467	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6ST—ovarian cancer	5.28e-05	0.000465	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CD—ovarian cancer	5.25e-05	0.000462	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6ST—ovarian cancer	5.22e-05	0.00046	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—ovarian cancer	5.2e-05	0.000458	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK3—ovarian cancer	5.19e-05	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—ovarian cancer	5.14e-05	0.000453	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—ovarian cancer	5.14e-05	0.000452	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CB—ovarian cancer	5.08e-05	0.000448	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—ovarian cancer	5.08e-05	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—ovarian cancer	5.08e-05	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—ovarian cancer	5.08e-05	0.000447	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYTB—ovarian cancer	5.03e-05	0.000443	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—ovarian cancer	5.02e-05	0.000442	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—ovarian cancer	5.02e-05	0.000442	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—ovarian cancer	5.02e-05	0.000442	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK1—ovarian cancer	4.94e-05	0.000435	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—ovarian cancer	4.94e-05	0.000435	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.92e-05	0.000433	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—ovarian cancer	4.89e-05	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK3—ovarian cancer	4.86e-05	0.000428	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK3—ovarian cancer	4.8e-05	0.000423	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CD—ovarian cancer	4.77e-05	0.00042	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—ovarian cancer	4.72e-05	0.000416	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—ovarian cancer	4.72e-05	0.000416	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—ovarian cancer	4.67e-05	0.000411	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—ovarian cancer	4.67e-05	0.000411	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—ovarian cancer	4.65e-05	0.00041	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—ovarian cancer	4.64e-05	0.000408	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK1—ovarian cancer	4.63e-05	0.000407	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—ovarian cancer	4.62e-05	0.000407	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—ovarian cancer	4.57e-05	0.000403	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CB—ovarian cancer	4.57e-05	0.000403	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK1—ovarian cancer	4.57e-05	0.000402	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—ovarian cancer	4.57e-05	0.000402	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CD—ovarian cancer	4.46e-05	0.000393	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—ovarian cancer	4.42e-05	0.000389	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CD—ovarian cancer	4.41e-05	0.000388	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPP1CC—ovarian cancer	4.4e-05	0.000387	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BRIP1—ovarian cancer	4.4e-05	0.000387	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—ovarian cancer	4.4e-05	0.000387	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—ovarian cancer	4.37e-05	0.000385	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—ovarian cancer	4.37e-05	0.000385	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—ovarian cancer	4.37e-05	0.000385	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—ovarian cancer	4.32e-05	0.00038	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CAV1—ovarian cancer	4.3e-05	0.000379	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—ovarian cancer	4.29e-05	0.000378	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—ovarian cancer	4.29e-05	0.000377	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—ovarian cancer	4.25e-05	0.000374	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—ovarian cancer	4.21e-05	0.000371	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—ovarian cancer	4.21e-05	0.00037	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—ovarian cancer	4.2e-05	0.00037	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—ovarian cancer	4.18e-05	0.000368	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CB—ovarian cancer	4.15e-05	0.000366	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—ovarian cancer	4.15e-05	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ESR1—ovarian cancer	4.15e-05	0.000365	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—ovarian cancer	4.1e-05	0.000361	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6ST—ovarian cancer	4.08e-05	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—ovarian cancer	4.06e-05	0.000357	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—ovarian cancer	4.01e-05	0.000353	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—ovarian cancer	3.99e-05	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—ovarian cancer	3.98e-05	0.00035	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—ovarian cancer	3.97e-05	0.000349	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—ovarian cancer	3.97e-05	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—ovarian cancer	3.95e-05	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—ovarian cancer	3.94e-05	0.000347	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—ovarian cancer	3.92e-05	0.000345	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—ovarian cancer	3.92e-05	0.000345	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—ovarian cancer	3.92e-05	0.000345	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—ovarian cancer	3.9e-05	0.000343	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—ovarian cancer	3.89e-05	0.000343	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—ovarian cancer	3.89e-05	0.000342	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CB—ovarian cancer	3.89e-05	0.000342	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—ovarian cancer	3.86e-05	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—ovarian cancer	3.86e-05	0.000339	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CB—ovarian cancer	3.84e-05	0.000338	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—ovarian cancer	3.84e-05	0.000338	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—ovarian cancer	3.82e-05	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—ovarian cancer	3.81e-05	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—ovarian cancer	3.8e-05	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK3—ovarian cancer	3.75e-05	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—ovarian cancer	3.74e-05	0.000329	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—ovarian cancer	3.72e-05	0.000327	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—ovarian cancer	3.71e-05	0.000327	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—ovarian cancer	3.69e-05	0.000325	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—ovarian cancer	3.68e-05	0.000324	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—ovarian cancer	3.67e-05	0.000323	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—ovarian cancer	3.65e-05	0.000321	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—ovarian cancer	3.61e-05	0.000318	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—ovarian cancer	3.61e-05	0.000318	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—ovarian cancer	3.61e-05	0.000318	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—ovarian cancer	3.59e-05	0.000316	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—ovarian cancer	3.58e-05	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—ovarian cancer	3.57e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK1—ovarian cancer	3.57e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—ovarian cancer	3.57e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—ovarian cancer	3.57e-05	0.000314	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—ovarian cancer	3.57e-05	0.000314	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—ovarian cancer	3.55e-05	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—ovarian cancer	3.53e-05	0.000311	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—ovarian cancer	3.53e-05	0.000311	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—ovarian cancer	3.53e-05	0.000311	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—ovarian cancer	3.53e-05	0.00031	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—ovarian cancer	3.51e-05	0.000309	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—ovarian cancer	3.5e-05	0.000308	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—ovarian cancer	3.48e-05	0.000307	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—ovarian cancer	3.45e-05	0.000304	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CD—ovarian cancer	3.45e-05	0.000303	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—ovarian cancer	3.44e-05	0.000303	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.41e-05	0.0003	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—ovarian cancer	3.41e-05	0.0003	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—ovarian cancer	3.38e-05	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK3—ovarian cancer	3.38e-05	0.000297	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—ovarian cancer	3.37e-05	0.000297	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—ovarian cancer	3.36e-05	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—ovarian cancer	3.34e-05	0.000294	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—ovarian cancer	3.32e-05	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—ovarian cancer	3.28e-05	0.000289	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	3.28e-05	0.000289	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—ovarian cancer	3.24e-05	0.000285	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	3.24e-05	0.000285	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK1—ovarian cancer	3.21e-05	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—ovarian cancer	3.21e-05	0.000283	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—ovarian cancer	3.21e-05	0.000283	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.21e-05	0.000282	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—ovarian cancer	3.2e-05	0.000282	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.1e-05	0.000273	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK3—ovarian cancer	3.07e-05	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	3.04e-05	0.000268	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	3.04e-05	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—ovarian cancer	3.04e-05	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—ovarian cancer	3.01e-05	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	3e-05	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	3e-05	0.000264	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	3e-05	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—ovarian cancer	3e-05	0.000264	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—ovarian cancer	2.98e-05	0.000263	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—ovarian cancer	2.97e-05	0.000261	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—ovarian cancer	2.96e-05	0.000261	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—YAP1—ovarian cancer	2.95e-05	0.00026	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.92e-05	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK1—ovarian cancer	2.92e-05	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—ovarian cancer	2.92e-05	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	2.89e-05	0.000254	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	2.87e-05	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	2.87e-05	0.000252	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	2.84e-05	0.00025	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	2.82e-05	0.000248	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—ovarian cancer	2.79e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—ovarian cancer	2.79e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	2.79e-05	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	2.76e-05	0.000243	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—ovarian cancer	2.76e-05	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—ovarian cancer	2.76e-05	0.000243	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—ovarian cancer	2.76e-05	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	2.74e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	2.73e-05	0.000241	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—ovarian cancer	2.73e-05	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	2.7e-05	0.000238	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—ovarian cancer	2.7e-05	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—ovarian cancer	2.7e-05	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	2.69e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	2.66e-05	0.000234	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	2.61e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	2.59e-05	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—ovarian cancer	2.58e-05	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—ovarian cancer	2.58e-05	0.000227	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.57e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—ovarian cancer	2.55e-05	0.000225	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—ovarian cancer	2.53e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	2.53e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—ovarian cancer	2.47e-05	0.000217	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—ovarian cancer	2.45e-05	0.000216	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FASN—ovarian cancer	2.41e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	2.37e-05	0.000209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.37e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	2.34e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	2.34e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—ovarian cancer	2.34e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	2.32e-05	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	2.32e-05	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—ovarian cancer	2.29e-05	0.000202	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.29e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—ovarian cancer	2.28e-05	0.000201	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—ovarian cancer	2.27e-05	0.0002	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—ovarian cancer	2.24e-05	0.000197	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.24e-05	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	2.22e-05	0.000195	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—ovarian cancer	2.19e-05	0.000193	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.19e-05	0.000193	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—ovarian cancer	2.17e-05	0.000191	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—ovarian cancer	2.16e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	2.11e-05	0.000186	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	2.11e-05	0.000186	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—ovarian cancer	2.1e-05	0.000185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—ovarian cancer	2.07e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—ovarian cancer	2.07e-05	0.000182	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	1.99e-05	0.000175	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.94e-05	0.000171	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—ovarian cancer	1.94e-05	0.000171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.93e-05	0.00017	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—ovarian cancer	1.91e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	1.83e-05	0.000161	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.8e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMS—ovarian cancer	1.77e-05	0.000156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—ovarian cancer	1.77e-05	0.000156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	1.69e-05	0.000149	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—ovarian cancer	1.62e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	1.5e-05	0.000132	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAV1—ovarian cancer	1.43e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.36e-05	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.3e-05	0.000115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.000101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CB—ovarian cancer	9.97e-06	8.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—ovarian cancer	8.61e-06	7.58e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—ovarian cancer	6.08e-06	5.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—ovarian cancer	4.96e-06	4.37e-05	CbGpPWpGaD
